PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain
BSE121.30-2.15 (-1.74 %)
PREV CLOSE ( ) 123.45
OPEN PRICE ( ) 124.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16279
TODAY'S LOW / HIGH ( )120.35 127.40
52 WK LOW / HIGH ( )107.15 202.2
NSE121.55-1.95 (-1.58 %)
PREV CLOSE( ) 123.50
OPEN PRICE ( ) 123.90
BID PRICE (QTY) 121.55 (5489)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 300190
TODAY'S LOW / HIGH( ) 120.30 127.60
52 WK LOW / HIGH ( )107 202.5
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax128.0514493.56-1450.30-1773.44462.25
Adjustment-958.69-14549.672308.812530.44-705.78
Changes In working Capital-3369.113008.63219.08-974.961273.21
Cash Flow after changes in Working Capital-4199.752952.521077.59-217.961029.68
Cash Flow from Operating Activities-4224.52-1084.481067.64-304.701047.96
Cash Flow from Investing Activities4303.3112825.73-476.79-347.60-52.70
Cash Flow from Financing Activities-183.73-11758.41-471.10907.39-1011.40
Net Cash Inflow / Outflow-104.94-17.16119.75255.09-16.14
Opening Cash & Cash Equivalents503.50520.79402.18144.66164.37
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANA-1.142.43-3.57
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations-0.04-0.13NANANA
Closing Cash & Cash Equivalent398.52503.50520.79402.18144.66

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.